After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...

Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...

CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, ...

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

As HR's strategic role evolves, people professionals must leverage tech alongside human skills to drive success, says BVI ...

Novartis has moved a step closer to EU approval ... The optional sensor attaches to the base of the Breezhaler device and collects data on the use of the inhaler, sending data remotely to an ...

AI has led to a boom in new startup creation and deal making, and BI startups that have strong founding teams and investor ...

What’s the full story? Seaport lays out a bullish case, starting with the massive total addressable market for groceries, ...

It will also expand its user base and double down on offerings for ... 400 enterprise customers — including the likes of Audi, Novartis, and P&G. What it does: Landbase uses AI agents to ...

This led to some of the major pharma companies setting up shop in the country, such as Novartis, GSK ... As the industry grew, a vibrant talent base and extraordinary levels of compliance with ...

Hello there. I don’t know if Mitsotakis got off easy back in 2018 with the rolling suitcases of the Novartis scandal—"the scandal of the century," as Mimi ...

Novartis exceeds Q4 2024 expectations with 16% sales growth, strong EPS trajectory, and strategic R&D investments. Read why ...